Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Injectable skin boosters effectively rejuvenate aging skin by improving hydration and elasticity.

Both skin products were equally effective in improving facial discoloration and skin quality.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Different doses of triamcinolone injections work equally well for skin conditions.

The fractional ultrapulse CO2 laser is a safe and effective non-surgical treatment for upper eyelid issues and brow lifting.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Bimatoprost can help regrow eyelashes in people with trichotillomania.

Scalp microinfusion with dutasteride is a safe and promising treatment for male hair loss.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Juvéderm fillers effectively reduce wrinkles for up to 21 months with less filler needed for repeat treatments.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Bismuth subgallate and borneol together improve skin wound healing better than when used separately or compared to other treatments.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

TAK-279 effectively reduces psoriasis symptoms and is safe.